These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2657277)

  • 1. Efficiency of multimodal smoking cessation therapy combining transdermal nicotine substitution with behavioral therapy.
    Buchkremer G; Minneker E
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):215-8. PubMed ID: 2657277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking-cessation treatment combining transdermal nicotine substitution with behavioral therapy.
    Buchkremer G; Minneker E; Block M
    Pharmacopsychiatry; 1991 May; 24(3):96-102. PubMed ID: 1891488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL; Jones L; Lancaster T; Fowler GH
    Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of behavioral smoking cessation with transdermal nicotine substitution.
    Buchkremer G; Bents H; Horstmann M; Opitz K; Tölle R
    Addict Behav; 1989; 14(2):229-38. PubMed ID: 2728961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Smoking cessation with the nicotine patch].
    Batra A; Buchkremer G
    Z Arztl Fortbild (Jena); 1995 Oct; 89(5):505-9. PubMed ID: 8578778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term effects of a combination of transdermal nicotine administration with behavior therapy for smoking cessation].
    Buchkremer G; Bents H; Minneker E; Opitz K
    Nervenarzt; 1988 Aug; 59(8):488-90. PubMed ID: 3050570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
    Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of different dosages of a transdermal nicotine substitution system on the success rate of smoking cessation therapy.
    Minneker E; Buchkremer G; Block M
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):219-22. PubMed ID: 2725119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling.
    Sachs DP; Säwe U; Leischow SJ
    Arch Intern Med; 1993 Aug; 153(16):1881-90. PubMed ID: 8110249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal nicotine patch enhances type I collagen synthesis in abstinent smokers.
    Sørensen LT; Jorgensen LN; Zillmer R; Vange J; Hemmingsen U; Gottrup F
    Wound Repair Regen; 2006; 14(3):247-51. PubMed ID: 16808802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
    Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
    Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precessation treatment with nicotine skin patch facilitates smoking cessation.
    Rose JE; Behm FM; Westman EC; Kukovich P
    Nicotine Tob Res; 2006 Feb; 8(1):89-101. PubMed ID: 16497603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal nicotine in smoking cessation and involvement of non-specific influences.
    Merz PG; Keller-Stanislawski B; Huber T; Woodcock BG; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):476-82. PubMed ID: 8262685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nicotine patch in smoking cessation. A randomized trial with telephone counseling.
    Westman EC; Levin ED; Rose JE
    Arch Intern Med; 1993 Aug; 153(16):1917-23. PubMed ID: 8250653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
    Cinciripini PM; Tsoh JY; Wetter DW; Lam C; de Moor C; Cinciripini L; Baile W; Anderson C; Minna JD
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):282-92. PubMed ID: 16366758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pros and cons of transdermal nicotine therapy.
    Gourlay S
    Med J Aust; 1994 Feb; 160(3):152-9. PubMed ID: 8295585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation.
    Lerman C; Tyndale R; Patterson F; Wileyto EP; Shields PG; Pinto A; Benowitz N
    Clin Pharmacol Ther; 2006 Jun; 79(6):600-8. PubMed ID: 16765148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short- and long-term smoking cessation for three levels of intensity of behavioral treatment.
    Alterman AI; Gariti P; Mulvaney F
    Psychol Addict Behav; 2001 Sep; 15(3):261-4. PubMed ID: 11563806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program.
    Alberg AJ; Stashefsky Margalit R; Burke A; Rasch KA; Stewart N; Kline JA; Ernst PA; Avey A; Hoffman SC
    Addict Behav; 2004 Dec; 29(9):1763-78. PubMed ID: 15530720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.